Medicine and Dentistry
Heart Failure
100%
Left Ventricular Assist Device
88%
Heart Transplantation
52%
Assisted Circulation
48%
Mobile Health
44%
Heart Failure with Preserved Ejection Fraction
44%
Combination Therapy
44%
Patient-Reported Outcome
44%
Exercise
32%
Clinical Trial
29%
Symptom
23%
Ventricular Septal Defect
22%
Cytomegalovirus
22%
Exercise Tolerance
22%
Cardiac Allograft Vasculopathy
22%
Heart Graft
22%
Patient Social Context
22%
Pulmonary Function Testing
22%
Graft Failure
22%
Forced Expiratory Volume
22%
Digoxin
22%
Case-Control Study
22%
Congestive Heart Failure
22%
Heart Failure with Reduced Ejection Fraction
20%
Cardiogenic Shock
20%
Infarction
17%
Quality of Life
16%
Ventricular Assist Device
13%
Drug Therapy
13%
Hemodynamic
12%
Hemodynamic Support
12%
Ejection Fraction
10%
Dyspnea
8%
Myocardial Infarction
8%
Graft Dysfunction
8%
Patient Population
8%
Gastrointestinal Bleeding
8%
Kaplan Meier Method
8%
Transplantation
8%
Randomized Controlled Trial
8%
Six Minute Walk Test
7%
Hazard Ratio
7%
Heart Preservation
7%
Wide Range Achievement Test
6%
Acute Heart Infarction
6%
Univariate Analysis
5%
Clinical Research
5%
Drug Abuse
5%
Diagnosis of Depression
5%
Acute Decompensated Heart Failure
5%
Disease
5%
Heart Right Ventricle Failure
5%
Cumulative Incidence
5%
Creatinine
5%
Health Care Economics
5%
Multivariate Analysis
5%
Health Care
5%
Odds Ratio
5%
Self Monitoring
5%
Keyphrases
Heart Transplantation
55%
Heart Transplant
24%
Temporary Mechanical Circulatory Support
22%
Preserved Ejection Fraction
22%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
22%
Meta-analysis of Randomized Controlled Trials
22%
Emerging Epidemics
22%
Amiodarone
22%
Barriers to Therapy
22%
Post-transplant Survival
22%
Ventricular Septal Defect Repair
22%
Exercise Tolerance
22%
Systematic Meta-analysis
22%
Heart Failure with Preserved Ejection Fraction (HFpEF)
22%
Primary Graft Dysfunction
22%
Forced Expiratory Volume in 1 Second (FEV1)
22%
Left Ventricular Ejection Fraction
22%
Cardiac Allograft Vasculopathy
22%
Mechanical Circulatory Support Device
22%
Pulmonary Function Test
22%
SherpaPak
22%
Patient-reported Outcomes
22%
Heart Failure
22%
Guideline-directed Medical Therapy
22%
Confidence Interval
20%
Patients with Heart Failure
17%
Hazard Ratio
16%
Cardiogenic Shock
15%
Heart Failure Hospitalization
15%
Multidrug
14%
Cardiovascular Mortality
13%
Randomized Controlled Trial
12%
VCO2
11%
VO2peak
11%
Composite Outcome
8%
Placebo
8%
Ventilation
8%
Length of Stay
7%
Long Length
7%
Increased Mortality
7%
Virtual Visits
6%
Acute Myocardial Infarction
6%
Cardiopulmonary Exercise Testing
5%
Drug Abuse History
5%
Resource Identification
5%
Nursing and Health Professions
Heart Failure
94%
Practice Guideline
55%
Combination Therapy
44%
Self Care
37%
Hospital
32%
Pilot Study
29%
Hospital Readmission
27%
Drug Therapy
22%
Primary Graft Dysfunction
22%
Symptom
22%
Left Ventricular Assist Device
22%
Patient Social Context
22%
Heart Failure with Preserved Ejection Fraction
22%
Patient-Reported Outcome
22%
Congestive Heart Failure
22%
Quality of Life
17%
Heart Failure with Reduced Ejection Fraction
11%
Healthcare System
11%
Self Monitoring
9%
Clinical Outcome
8%
Heart Ejection Fraction
8%
Health Care Utilization
7%
Health Auxiliary
7%
Nurse Practitioner
7%
Heart Preservation
7%
Dyspnea
7%
Confidence Interval
5%
Heart Transplantation
5%
Disease
5%
Length of Stay
5%
Patient Population
5%
Univariate Analysis
5%
Acute Heart Failure
5%
Odds Ratio
5%
Multivariate Analysis
5%